Clinical Development

Clinical Monitoring

Clinical research monitoring for a successful, compliant and safe clinical study.

Monitoring Your Trails On the Right Path

Located all over the world, our dedicated, professional monitoring team is the key to enhancing your study quality, improving patient safety and advancing research efficiency. All Tigermed clinical monitoring team members receive the latest new techniques and technologies via continuous training to ensure they can address any complexities in modern clinical trials.

Our clinical monitoring capabilities provide unique performance for all phases of global clinical research, including site feasibility, site start-up, site monitoring (SIV, IMV, SCV), QC and audit inspection support, remote monitoring, risk-based monitoring, etc.

Oncology Projects
130+
Projects in the other therapeutic areas
200+

Medical Monitoring Projects

330+

Clinical Research Associates (CRAs)

Specialization and team stability

Commitment to high quality in clinical trials

Implementation of multi-regional clinical trials

Our Capabilities

Medical Science

  • Develop the medical monitoring plan (MMP)
  • Provide medical review of the protocol and CSR

Clinical Operation Service

  • Provide medical training (including MMP, protocol, related TA etc.)
  • Subject eligibility review
  • Protocol deviations review
  • Medical consultation
  • 24/7 medical coverage

Data Management

  • Offer medical review of CRF
  • Medical review for clinical data and medical support for data cleaning

Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine

From late 2020 to early 2021, Tigermed teamed up with CanSinoBio and Pakistan local expert, as well as clinical professionals from Mexico, Russia, Chile, Argentina, to conduct Phase III trial of COVID-19 vaccine and ultimately delivered the study. This is also the first China-initiated phase III vaccine clinical study covering multiple continents, including Asia, Europe, and Latin America.

Let's Connect for a Conversation